EVALUATION OF BLOOD PRESSURE REDUCTION, SAFETY, AND TOLERABILITY OF CANAGLIFLOZIN IN PATIENTS WITH HYPERTENSION AND TYPE 2 DIABETES MELLITUS ON STABLE DOSES OF ANTI-HYPERGLYCEMIC AND ANTI-HYPERTENSIVE AGENTS: